Table 2.
Reference | Comparisons | Drug dose | Age (years) |
Duration of illness (years) |
YGTSS | Outcomes | Duration of intervention | Duration of follow-up |
---|---|---|---|---|---|---|---|---|
Guo et al., 2004 [36] | Electroacupuncture (n = 68) | 1.5–8 mg/d | NR | 1 to 8 in two groups | NR | Response rate | 30 days (30 sessions) |
No follow-up |
Haloperidol (n = 34) | ||||||||
| ||||||||
Liu et al., 2010 [30] | Electroacupuncture (n = 30) | 1.5–8 mg/d | NR | 1 to 5 | NR | Response rate | 20 days (20 sessions) |
No follow-up |
Haloperidol (n = 30) | 1 to 5 | |||||||
| ||||||||
Xu and Zhu, 2009 [33] | Scalp acupuncture (n = 30) | 0.25–1 mg/d | 6 to 18 | 1 to 7 | 30.07 ± 2.76 | YGTSS, response rate | 3 months (39 sessions) |
No follow-up |
Risperidone (n = 30) | 4 to 17 | 1 to 8 | 35.03 ± 3.46 | |||||
| ||||||||
Zhang et al., 2015 [34] | Manual acupuncture (n = 44) | 150–450 mg/d | 2 to 15 in two groups | 0.5 to 3.2 in two groups | NR | Response rate | 3 months (60 sessions) |
No follow-up |
Tiapride (n = 43) | ||||||||
| ||||||||
Mu et al., 2009 [35] | Electroacupuncture plus psychological behaviour therapy (n = 60) | From 1 mg/d | 10.24 ± 3.41 | 2.15 ± 1.07 | 33.61 ± 5.76 | YGTSS, response rate | 6 weeks (42 sessions) |
No follow-up |
Haloperidol plus psychological behaviour therapy (n = 60) | 9.53 ± 2.75 | 2.48 ± 1.55 | 31.08 ± 6.54 | |||||
| ||||||||
Chi and Sun, 2004 [37] | Manual acupuncture plus haloperidol (n = 24) | 1.5–8 mg | 2 to 21 | 1 to 9 | 39.875 ± 15.875 | YGTSS, response rate | 20 days (20 sessions) |
No follow-up |
Haloperidol (n = 21) | 2 to 21 | 1 to 9 | 40.190 ± 15.863 | |||||
| ||||||||
Yang et al., 2007 [38] | Manual acupuncture plus haloperidol and psychotherapy (n = 60 initially; final n = 56) | From 1 mg/d | 11.52 ± 2.96 | NR | 34.26 ± 5.88 | YGTSS, response rate | 40 days (40 sessions) |
No follow-up |
Haloperidol and psychotherapy (n = 30) | 12.03 ± 3.37 | 36.01 ± 6.73 |
YGTSS: Yale Global Tic Severity Scale. NR: no reported.